CytomX Therapeutics Inc CTMX:NASDAQ

Last Price$1.86NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/28/22

Today's Change-0.08(4.12%)
Bid (Size)$1.85 (14)
Ask (Size)$2.00 (17)
Day Low / High$1.82 - 1.94
Volume875.9 K

CytomX Therapeutics' 2021 Loss Widens, Revenue Declines

5:28PM ET 3/01/2022 MT Newswires
CytomX Therapeutics (CTMX) said Tuesday its 2021 net loss widened to $1.30 per share from $0.71 per share a year earlier.

Analysts polled by Capital IQ expected a $1.17 loss per share for the year.

Revenue fell to $69.6 million from $100.4 million a year ago. The Street estimated $75.42 million.

Looking ahead, the clinical-stage drugmaker expects to start a phase 1 study of CX-904 in advanced solid tumors in the first half of this year, and also to continue patient enrollment in the expansion phase of the mid-stage study of CX-2029 and provide more data in the second half of 2022.

Price: 3.9, Change: +0.36, Percent Change: +10.17